Loading...
menu
Search
AI Trading Bot
Features
Markets
News
Resources
Pricing
Get Started
Home
Stock
VRDN
VRDN News & Events
-
Add to Watchlist
Trade VRDN Autonomously
$
0.000
0.000
(
0.000%
)
At close
0.000
(
0.000%
)
Aft-market
ET
$
0.000
0.000
(
0.000%
)
At close
0.000
(
0.000%
)
Aft-market
ET
Overview
Stock Price Prediction
Technical
Valuation
Financials
Earnings
Should I Buy
News & Events
VRDN News
HighVista Strategies Reduces Stake in Viridian Therapeutics
May 17 2026
Fool
HighVista Strategies Cuts Stake in Viridian Therapeutics by $7 Million
May 17 2026
Yahoo Finance
Viridian Therapeutics Raises $350M Through Upsized Public Offerings
May 07 2026
seekingalpha
Viridian Therapeutics Completes $225 Million Financing
May 07 2026
Newsfilter
Viridian Therapeutics Reveals Pricing for Increased Concurrent Public Offerings of 1.75% Convertible Senior Notes Due 2032 and Common Stock, Targeting Total Gross Proceeds of $350 Million
May 07 2026
moomoo
Viridian Therapeutics Stock Soars 33.36% Amid Treatment Launch
May 06 2026
Yahoo Finance
Viridian's Therapy Shows Strong Results, Stock Surges
May 05 2026
stocktwits
Kopp Family Office Reduces Stake in Viridian Therapeutics
Apr 21 2026
Fool
Show More News
VRDN Events
05/07 06:20
Deal Size Increased to $125M in Common Stock
The deal size was increased to $125M in common stock from $100M in common stock. Jefferies, Leerink and Goldman Sachs acted as joint book running managers for the offering.
Show More Events
VRDN Monitor News
HighVista Strategies Cuts Stake in Viridian Therapeutics Amid FDA Decision
May 20 2026
Viridian Therapeutics reaches 20-day high amid market gains
May 05 2026
Viridian Therapeutics Shares Plunge After Phase 3 Trial Results
Apr 06 2026
Viridian Therapeutics Shares Plunge After Mixed Trial Results
Mar 30 2026
VRDN Earnings Analysis
No Data
People Also Watch
